Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

Vitamin D and cancer

Ali Minu M, Vaidya V

Year : 2007| Volume: 3| Issue : 4 | Page no: 225-230

   This article has been cited by
 
1 Vitamin D receptor and retinoid X receptor α status and vitamin D insufficiency in models of murine colitis
Knackstedt, R.W. and Moseley, V.R. and Sun, S. and Wargovich, M.J.
Cancer Prevention Research. 2013; 6(6): 585-593
[Pubmed]  [Google Scholar]
2 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells
Guan, H. and Liu, C. and Chen, Z. and Wang, L. and Li, C. and Zhao, J. and Yu, Y. and Zhang, P. and Chen, W. and Jiang, A.
Gene. 2013; 522(2): 142-146
[Pubmed]  [Google Scholar]
3 Impact of seasonal and geographical differences on breast cancer survival
Hyun Wook Kwon,Jung Won Lee,Hee Jeong Kim,Beom Seok Koh,Jong Han Yu,Jong Won Lee,Byung Ho Son,Sei Hyun Ahn
Korean Journal of Clinical Oncology. 2013; 9(2): 168
[Pubmed]  [Google Scholar] [DOI]
4 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells
Hengyun Guan,Chunyan Liu,Zhaobo Chen,Lina Wang,Chaoyang Li,Jian Zhao,Yang Yu,Pengju Zhang,Weiwen Chen,Anli Jiang
Gene. 2013; 522(2): 142
[Pubmed]  [Google Scholar] [DOI]
5 Lifestyle and dietary factors in the prevention of lethal prostate cancer
Kathryn M Wilson, Edward L Giovannucci, Lorelei A Mucci
Asian Journal of Andrology. 2012;
[HTML Full text]  [Google Scholar] [DOI]
6 Dietary derived compounds in cancer chemoprevention
Langner, E. and Rzeski, W.
Wspolczesna Onkologia. 2012; 16(5): 394-400
[Pubmed]  [Google Scholar]
7 25(OH)D3 in patients with ovarian cancer and its correlation with survival
Walentowicz-Sadlecka, M. and Grabiec, M. and Sadlecki, P. and Gotowska, M. and Walentowicz, P. and Krintus, M. and Mankowska-Cyl, A. and Sypniewska, G.
Clinical Biochemistry. 2012; 45(18): 1568-1572
[Pubmed]  [Google Scholar]
8 25(OH)D3 in patients with ovarian cancer and its correlation with survival
M. Walentowicz-Sadlecka,M. Grabiec,P. Sadlecki,M. Gotowska,P. Walentowicz,M. Krintus,A. Mankowska-Cyl,G. Sypniewska
Clinical Biochemistry. 2012; 45(18): 1568
[Pubmed]  [Google Scholar] [DOI]
9 Blood serum hydroxyvitamin D concentration in ovarian cancer [Stȩżenie 25-hydroksywitaminy D w surowicy krwi chorych na raka jajnika]
Pardej, A. and Czerw, K. and Gryboś, M. and Guzikowski, W.
Ginekologia i Poloznictwo. 2011; 22(4): 63-68
[Pubmed]  [Google Scholar]
10 Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: A case control study
Fidan, E. and Yildiz, B. and Ozdemir, F. and Ucar, U. and Kavgaci, H. and MOrem, A. and Aydin, F.
Asian Biomedicine. 2011; 5(5): 663-667
[Pubmed]  [Google Scholar]
11 Vitamin D status in patients with Behcets disease
Karatay, S. and Yildirim, K. and Karakuzu, A. and Kiziltunc, A. and Engin, R.I. and Eren, Y.B. and Aktas, A.
Clinics. 2011; 66(5): 721-723
[Pubmed]  [Google Scholar]
12 The influence of vitamin D receptor gene polymorphism on basal cell carcinoma development in the Polish population
Lesiak, A. and Wódz-Naskiewicz, K. and Pawliczak, R. and Rogowski-Tylman, M. and Sysa-Jȩdrzejowska, A. and Sobjanek, M. and Włodarkiewicz, A. and Narbutt, J.
Postepy Dermatologii i Alergologii. 2011; 28(3): 165-169
[Pubmed]  [Google Scholar]
13 Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis
Gilbert, R. and Martin, R.M. and Beynon, R. and Harris, R. and Savovic, J. and Zuccolo, L. and Bekkering, G.E. and Fraser, W.D. and Sterne, J.A.C. and Metcalfe, C.
Cancer Causes and Control. 2011; 22(3): 319-340
[Pubmed]  [Google Scholar]
14 Vitamin D as a promising anticancer agent
Chakraborti, C.
Indian Journal of Pharmacology. 2011; 43(2): 113-120
[Pubmed]  [Google Scholar]
15 Plasma vitamin D levels and vitamin D receptor polymorphisms are associated with survival of non-small cell lung cancer
Yong-qian Shu, Shi-yang Pan, Jun-cheng Dai, Guang-fu Jin, Hong-xia Ma, Hong-bing Shen, Yao Liu, Wei Chen, Zhi-bin Hu, Lin Xu
Chinese Journal of Cancer Research. 2011; 23(1): 33
[HTML Full text]  [Google Scholar] [DOI]
16 Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and doseresponse meta-analysis
Rebecca Gilbert,Richard M. Martin,Rebecca Beynon,Ross Harris,Jelena Savovic,Luisa Zuccolo,Geertruida E. Bekkering,William D. Fraser,Jonathan A. C. Sterne,Chris Metcalfe
Cancer Causes & Control. 2011; 22(3): 319
[Pubmed]  [Google Scholar] [DOI]
17 Pediatric 25-hydroxyvitamin D concentrationsin neurofibromatosis type 1
Journal of Pediatric Endocrinology and Metabolism. 2011; 24(3-4): 169
[HTML Full text]  [Google Scholar] [DOI]
18 Thyroid Cancer Resistance to Vitamin D Receptor Activation Is Associated with 24-Hydroxylase Levels But Not theffFokI Polymorphism
Vibha Sharma,Deborah Fretwell,Zachary Crees,Anna Kerege,Joshua P. Klopper
Thyroid. 2010; 20(10): 1103
[Pubmed]  [Google Scholar] [DOI]
19 Role of Vitamin D3 as a Sensitizer to Cryoablation in a Murine Prostate Cancer Model: Preliminary In Vivo Study
Masaki Kimura,Zahid Rabbani,Vladimir Mouraviev,Matvey Tsivian,Jorge Caso,Takefumi Satoh,Shiro Baba,Zeljko Vujaskovic,John M. Baust,John G. Baust,Thomas J. Polascik
Urology. 2010; 76(3): 764.e14
[Pubmed]  [Google Scholar] [DOI]
20 Role of vitamin D3 as a sensitizer to cryoablation in a murine prostate cancer model: Preliminary in vivo study
Kimura, M., Rabbani, Z., Mouraviev, V., Tsivian, M., Caso, J., Satoh, T., Baba, S., (...), Polascik, T.J.
Urology. 2010; 76(3): e14-e20
[Pubmed]  [Google Scholar]
21 Current second-line treatment options for patients with castration resistant prostate cancer (CRPC) resistant to docetaxel
Christian Arsov, Christian Winter, Robert Rabenalt, Peter Albers
Urologic Oncology Seminars and Original Investigations. 2010;
[HTML Full text]  [Google Scholar] [DOI]
22 Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death
C.M. Brosseau,G. Pirianov,K.W. Colston
Steroids. 2010; 75(13-14): 1082
[Pubmed]  [Google Scholar] [DOI]
23 Chronic inflammation in the pathogenesis of benign prostatic hyperplasia
Fibbi, B., Penna, G., Morelli, A., Adorini, L., Maggi, M.
International Journal of Andrology. 2010; 33(3): 475-488
[Pubmed]  [Google Scholar]
24 Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism
Sharma, V., Fretwell, D., Crees, Z., Kerege, A., Klopper, J.P.
Thyroid. 2010; 20(10): 1103-1111
[Pubmed]  [Google Scholar]
25 Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death
Brosseau, C.M., Pirianov, G., Colston, K.W.
Steroids. 2010; 75(13-14): 1082-1088
[Pubmed]  [Google Scholar]
26 Dietary intakes of retinol, β-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohort
Jenab, M., Salvini, S., van Gils, C.H., Brustad, M., Shakya-Shrestha, S., Buijsse, B., Verhagen, H., Slimani, N.
European Journal of Clinical Nutrition. 2009; 63(Suppl 4): S150-S178
[Pubmed]  [Google Scholar] [DOI]
27 The promiscuous receptor
Thomas E. Newsom-Davis, Laura M. Kenny, Sarah Ngan, Judith King, Jonathan Waxman
BJU International. 2009; 104(9): 1204-1207
[Pubmed]  [Google Scholar] [DOI]
28 Chronic inflammation in the pathogenesis of benign prostatic hyperplasia
B. Fibbi,G. Penna,A. Morelli,L. Adorini,M. Maggi
International Journal of Andrology. 2009; 33(3): 475
[Pubmed]  [Google Scholar] [DOI]
29 Vitamin D: A D-lightful health supplement
Mullin, G.E., Turnbull, L., Kines, K.
Nutrition in Clinical Practice. 2009; 24(5): 642-644
[Pubmed]  [Google Scholar]
30 Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter
Eloranta, J.J., Hiller, C., Husler, S., Stieger, B., Kullak-Ublick, G.A.
Molecular Pharmacology. 2009; 76(5): 1062-1071
[Pubmed]  [Google Scholar]
31 Polymorphisms in the vitamin D receptor gene and risk of lung cancer
Dogan, I., Onen, H.I., Yurdakul, A.S., Konac, E., Ozturk, C., Varol, A., Ekmekci, A.
Medical Science Monitor. 2009; 15(8): BR232-BR242
[Pubmed]  [Google Scholar]
32 Vitamin D deficiency in older adults, part I: The prevention of chronic degenerative disease and support of immune health
Burford-Mason, A.
Geriatrics and Aging. 2009; 12(1): 43-47
[Pubmed]  [Google Scholar]
33 Review article: Vitamin D acquisition and breast cancer risk
Prez-Lpez, F.R., Chedraui, P., Haya, J.
Reproductive Sciences. 2009; 16(1): 7-19
[Pubmed]  [Google Scholar]
34 Vitamin D, vitamin D analogs (deltanoids) and prostate cancer
William M Brown
Expert Review of Clinical Pharmacology. 2008; 1(6): 803-813
[Pubmed]  [Google Scholar] [DOI]
35 Advances in vitamin D and inflammatory bowel disease
Ma, J.-C., Zhang, X.-L., Hao, L.-S., Liu, N.
World Chinese Journal of Digestology. 2008; 16(23): 2637-2643
[Pubmed]  [Google Scholar]
36 The Complex Role of Vitamin D in Autoimmune Diseases
P. Szodoray,B. Nakken,J. Gaal,R. Jonsson,A. Szegedi,E. Zold,G. Szegedi,J. G. Brun,R. Gesztelyi,M. Zeher,E. Bodolay
Scandinavian Journal of Immunology. 2008; 68(3): 261
[Pubmed]  [Google Scholar] [DOI]
37 Bladder Cancer: Chemoprevention, complementary approaches and budgetary considerations
Grossman, H.B. and Stenzl, A. and Moyad, M.A. and Droller, M.J.
Scandinavian Journal of Urology and Nephrology. 2008; 42(SUPPL.218): 213-233
[Pubmed]  [Google Scholar]
38 The Complex Role of Vitamin D in Autoimmune Diseases
Szodoray, P. and Nakken, B. and Gaal, J. and Jonsson, R. and Szegedi, A. and Zold, E. and Szegedi, G. and Brun, JG and Gesztelyi, R. and Zeher, M. and others
Scandinavian Journal of Immunology. 2008; 68(3): 261-269
[Pubmed]  [Google Scholar]

 

Read this article